RU2018147275A - A method for the treatment of type 2 diabetes in patients with steatohepatitis - Google Patents

A method for the treatment of type 2 diabetes in patients with steatohepatitis Download PDF

Info

Publication number
RU2018147275A
RU2018147275A RU2018147275A RU2018147275A RU2018147275A RU 2018147275 A RU2018147275 A RU 2018147275A RU 2018147275 A RU2018147275 A RU 2018147275A RU 2018147275 A RU2018147275 A RU 2018147275A RU 2018147275 A RU2018147275 A RU 2018147275A
Authority
RU
Russia
Prior art keywords
steatohepatitis
patients
treatment
type
diabetes
Prior art date
Application number
RU2018147275A
Other languages
Russian (ru)
Other versions
RU2018147275A3 (en
Inventor
Лариса Арсентьевна Звенигородская
Ашот Мусаелович Мкртумян
Светлана Владимировна Родионова
Михаил Викторович Шинкин
Алла Эдуардовна Лычкова
Original Assignee
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы filed Critical Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы
Priority to RU2018147275A priority Critical patent/RU2018147275A/en
Publication of RU2018147275A3 publication Critical patent/RU2018147275A3/ru
Publication of RU2018147275A publication Critical patent/RU2018147275A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (1)

Способ лечения сахарного диабета 2 типа у больных со стеатогепатитом, включающий лекарственную терапию, отличающийся тем, что в качестве лекарственного средства применяют препарат канаглифлозин в дозе 75-100 мг в течение 4-4,5 недель.A method for the treatment of type 2 diabetes mellitus in patients with steatohepatitis, including drug therapy, characterized in that the drug canagliflozin in a dose of 75-100 mg is used for 4-4.5 weeks.
RU2018147275A 2018-12-28 2018-12-28 A method for the treatment of type 2 diabetes in patients with steatohepatitis RU2018147275A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018147275A RU2018147275A (en) 2018-12-28 2018-12-28 A method for the treatment of type 2 diabetes in patients with steatohepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018147275A RU2018147275A (en) 2018-12-28 2018-12-28 A method for the treatment of type 2 diabetes in patients with steatohepatitis

Publications (2)

Publication Number Publication Date
RU2018147275A3 RU2018147275A3 (en) 2020-06-29
RU2018147275A true RU2018147275A (en) 2020-06-29

Family

ID=71509490

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018147275A RU2018147275A (en) 2018-12-28 2018-12-28 A method for the treatment of type 2 diabetes in patients with steatohepatitis

Country Status (1)

Country Link
RU (1) RU2018147275A (en)

Also Published As

Publication number Publication date
RU2018147275A3 (en) 2020-06-29

Similar Documents

Publication Publication Date Title
EP4272818A3 (en) Thrombolytic agent for the treatment of thromboembolism
EP4324521A3 (en) Treatment of fabry disease in ert-naive and ert-experienced patients
EA201791199A1 (en) METHOD OF TREATMENT OF ALZHEIMER'S DISEASE
JO3738B1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
MX2018012538A (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof.
EA201792030A1 (en) TREATMENT OF PATIENTS WITH DIABETES MELLITUS TYPE 2
EA202090242A1 (en) TREATMENT OF FABRY DISEASE IN FZT-NAIVE AND FZT-TREATED PATIENTS
AR103118A1 (en) ANAMORELINE-BASED MEDICAL TREATMENTS
RU2018139578A (en) A method of treating hyperglycemia
JP2016519107A5 (en)
JP2019529569A5 (en)
RU2018147275A (en) A method for the treatment of type 2 diabetes in patients with steatohepatitis
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.
EA202090165A1 (en) A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES ASSOCIATED WITH DIABETES, CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN, AND PREPARATION
RU2015154876A (en) METHOD FOR SURGICAL TREATMENT OF DIABETIC MACULAR Edema WITH VITREOMACULAR TRACTION
RU2015131803A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
RU2015130362A (en) Method and means for preoperative preparation of cancer patients with type 2 diabetes mellitus associated with obesity and cardiovascular disease
MX2023006765A (en) Method of providing celiprolol therapy to a patient.
RU2015148051A (en) A method for the treatment of periodontal disease in patients with type II diabetes
EA201991119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND ITS APPLICATION
Okong’o Lymphopenia: case report
MDS20160124U2 (en) Method for prophylaxis of prolonged lymphorrhagia in the radical treatment of breast cancer in patients with type 2 diabetes
UA96488U (en) A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease
UA111312C2 (en) Treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following transcutaneous transluminar coronary angioplasty
UA120513U (en) METHOD OF OPTIMIZATION OF TREATMENT OF NON-ALCOHOLIC STEATOGEPATITIS IN PATIENTS WITH ISCHEMIC HEART DISEASE